Bill Shingleton, Director, Applications & Biology – Cell & Gene Therapy at Cytiva presents a short video on the company’s collaboration within the NA-ATTC. The supply chain has a critical role in the custody and chain of identity of Advanced Therapy starting materials and manufactured products, and Cytiva’s work in the Consortium has supported the development and testing of its innovative supply chain technology.
